FY24-DOES Drug Screenings, Urinalysis & TB Testing Services

The District of Columbia's Department of Employment Services (DOES) is seeking comprehensive drug screening, urinalysis, and tuberculosis testing services for fiscal year 2024. This procurement aims to secure a vendor capable of providing medical screening and diagnostic services that support the agency's operational and compliance requirements. The contract will involve conducting drug screenings, urinalysis tests, and TB testing for agency personnel and potentially program participants, with an emphasis on accurate, timely, and professional medical testing procedures. Potential vendors must demonstrate expertise in clinical testing, maintain strict confidentiality protocols, and comply with all relevant medical testing standards and regulations. The solicitation requires interested contractors to submit detailed proposals demonstrating their technical capabilities, laboratory certifications, and past performance in similar medical screening environments. The proposal is due on November 13, 2023, with the initial posting occurring on October 24, 2023, providing approximately three weeks for potential bidders to prepare and submit comprehensive responses.

While specific set-aside designations are not explicitly detailed in the provided information, the District of Columbia typically encourages participation from local, small, and disadvantaged business enterprises in its procurement processes. The contract likely represents a significant opportunity for medical testing laboratories and healthcare service providers with established capabilities in workplace and clinical screening services. Though exact budget ranges are not specified, similar municipal contracts for medical screening services often range from $50,000 to $250,000 annually, depending on the volume of testing required. Potential respondents should be prepared to demonstrate robust quality control measures, CLIA certification, and the ability to handle confidential medical information in compliance with local and federal regulations. Vendors will likely be evaluated on criteria including technical capability, pricing structure, turnaround time for test results, geographical coverage, and demonstrated experience with government medical screening programs.